View in EDS HTML Full Text PDF Full Text

Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma.

Saved in:
Bibliographic Details
Title: Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma.
Authors: Stiff, Patrick J.1 (AUTHOR), Czerlanis, Cheryl M.1,2 (AUTHOR), Potkul, Ronald K.2,3 (AUTHOR), Liotta, Margaret2,4 (AUTHOR), Yu, Zheng3,5 (AUTHOR), Pease, Lori3,6 (AUTHOR), Banerjee, Swarnali4 (AUTHOR), Mehrotra, Swati5 (AUTHOR), Winder, Abigail2 (AUTHOR), Guevara, Jennifer6 (AUTHOR), Palmer, Diane6 (AUTHOR), Drakes, Maureen L.1 (AUTHOR) mdrakes@luc.edu
Source: Cancers. Apr2026, Vol. 18 Issue 8, p1285. 22p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers18081285